HLUN Stock Overview
Healtheuniverse, Inc., a biotechnology development company, engages in the research, development, and commercialization of biopharmaceutical, biomedical, nutraceutical, and cosmeceutical products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
HEALTHeUNIVERSE, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000016 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -84.00% |
| 3 Year Change | -99.57% |
| 5 Year Change | 1,500.00% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| HLUN | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | 1.5% | 1.2% |
| 1Y | -84.0% | 1.1% | 24.7% |
Return vs Industry: HLUN underperformed the US Biotechs industry which returned -3.7% over the past year.
Return vs Market: HLUN underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| HLUN volatility | |
|---|---|
| HLUN Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: HLUN has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HLUN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Vipul Dev | n/a |
Healtheuniverse, Inc., a biotechnology development company, engages in the research, development, and commercialization of biopharmaceutical, biomedical, nutraceutical, and cosmeceutical products. The company develops stem cell and regenerative medicine therapies utilizing non-embryonic adult stem cells for use in plastic and reconstructive surgery, orthopedic surgery, vascular surgery, cardiac surgery, and wound care. It also provides consulting services to various businesses in the areas of marketing, business organization, and raising capital for business ventures.
HEALTHeUNIVERSE, Inc. Fundamentals Summary
| HLUN fundamental statistics | |
|---|---|
| Market cap | US$1.88k |
| Earnings (TTM) | US$42.80k |
| Revenue (TTM) | US$481.79k |
0.0x
P/E Ratio0.0x
P/S RatioIs HLUN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HLUN income statement (TTM) | |
|---|---|
| Revenue | US$481.79k |
| Cost of Revenue | US$18.63k |
| Gross Profit | US$463.15k |
| Other Expenses | US$420.35k |
| Earnings | US$42.80k |
Last Reported Earnings
Sep 30, 2006
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did HLUN perform over the long term?
See historical performance and comparison